Comments

Soleno Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Soleno Therapeutics (SLNO) operate in?

Soleno Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SLNONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Soleno Therapeutics (SLNO) Forecast

News Earnings Soleno Therapeutics (SLNO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Soleno Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:SLNO | Benzinga

Explore Soleno Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SLNO.

Open	$79.74
Close	-
Volume / Avg.	70.69K / 1.31M
Day Range	$78.94 - $79.90
52 Wk Range	36.93 - 81.54
Market Cap	$4.02B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	9.11%
Days to Cover	6.43

Recent News

Tesla To $455? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

Soleno Shares Are Up Today: What's Going On?

Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares are trading higher Thursday after the company announced it secured FDA approval for its first commercial drug, Vykat XR (diazoxide choline) extended-release tablets.

Vaishali Prayag

Gold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$79.74
Close	-
Volume / Avg.	70.69K / 1.31M
Day Range	$78.94 - $79.90
52 Wk Range	36.93 - 81.54
Market Cap	$4.02B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	9.11%
Days to Cover	6.43

About Soleno Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatme...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Soleno Therapeutics (SLNO) stock?

You can purchase shares of Soleno Therapeutics (NASDAQ:SLNO) through any online brokerage.

View our list of the best stock brokerages

Who are Soleno Therapeutics (SLNO) competitors?

Other companies in Soleno Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).

What is the forecast, or price target, for Soleno Therapeutics (SLNO) stock?

Soleno Therapeutics has a consensus price target of $103.33.

What is the current price for Soleno Therapeutics (SLNO)?

The stock price for Soleno Therapeutics (NASDAQ: SLNO) is $79.235 last updated June 20, 2025 at 10:24 AM EDT.

Does Soleno Therapeutics (SLNO) pay a dividend?

There are no upcoming dividends for Soleno Therapeutics.

When is Soleno Therapeutics (NASDAQ:SLNO) reporting earnings?

Soleno Therapeutics’s Q2 earnings are confirmed for Wednesday, August 6, 2025.

Is Soleno Therapeutics (SLNO) going to split?

There is no upcoming split for Soleno Therapeutics.

What sector and industry does Soleno Therapeutics (SLNO) operate in?

Soleno Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.